ANI PHARMACEUTICALS, INC (ANIP) Stock buybacks 2016–2025
ANI PHARMACEUTICALS, INC (ANIP) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$12.2MFY2025 · since FY2016: $2.5M → $12.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $12.2M | +11.4% |
| FY2024 | $11.0M | +119.8% |
| FY2023 | $5.0M | +154.6% |
| FY2022 | $2.0M | +120.1% |
| FY2021 | $890,000 | -41.6% |
| FY2020 | $1.5M | +47.7% |
| FY2019 | $1.0M | — |
| FY2018 | $0 | — |
| FY2017 | $0 | -100.0% |
| FY2016 | $2.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ANIP financial trends
ANIP RevenueANIP Net incomeANIP Net marginANIP Gross profitANIP Gross marginANIP Operating incomeANIP Operating marginANIP Operating cash flowANIP Free cash flowANIP Capital expendituresANIP Return on equityANIP Dividends paidANIP Total assetsANIP Total liabilitiesANIP Shareholders’ equityANIP overview →